KAPA short interest
Kairos Pharma Ltd. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 113,181 |
|---|---|
| Change vs prior report | -1,207 (-1.1%) |
| Change over six months | -52.1% |
| Days to cover | 1.04 (sector: 3.78) |
| Average daily volume | 108,708 |
| Rank in Healthcare | #774 of 922 by days to cover |
KAPA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 113,181 | -1.1% | 1.04 | 108,708 |
| 2026-09-15 | 114,388 | -71.6% | 1.20 | 95,127 |
| 2026-08-31 | 403,209 | +10.7% | 1.00 | 488,074 |
| 2026-08-14 | 364,248 | -29.7% | 1.00 | 661,967 |
| 2026-07-31 | 517,820 | +169.5% | 1.00 | 7,426,518 |
| 2026-07-15 | 192,173 | +23.2% | 1.00 | 3,593,616 |
| 2026-06-30 | 155,940 | +0.6% | 1.11 | 140,922 |
| 2026-06-15 | 154,946 | -1.5% | 1.31 | 118,672 |
| 2026-05-29 | 157,342 | +29.7% | 1.00 | 194,351 |
| 2026-05-15 | 121,325 | -3.5% | 1.00 | 177,425 |
| 2026-04-30 | 125,693 | -14.3% | 1.04 | 121,021 |
| 2026-04-15 | 146,646 | -37.9% | 2.18 | 67,187 |
| 2026-03-31 | 236,224 | +19.1% | 2.25 | 105,134 |
| 2026-03-13 | 198,425 | -84.4% | 1.00 | 233,058 |
| 2026-02-27 | 1,274,209 | +601.2% | 1.00 | 2,687,153 |
| 2026-02-13 | 181,710 | +26.1% | 2.00 | 91,000 |
| 2026-01-30 | 144,124 | -24.9% | 1.00 | 181,961 |
| 2026-01-15 | 192,015 | +81.0% | 1.00 | 194,094 |
| 2025-12-31 | 106,098 | -5.2% | 1.00 | 172,755 |
| 2025-12-15 | 111,891 | -10.3% | 1.00 | 133,420 |
| 2025-11-28 | 124,743 | -0.6% | 1.00 | 134,986 |
| 2025-11-14 | 125,497 | -47.5% | 1.00 | 285,701 |
| 2025-10-31 | 239,099 | -13.0% | 1.00 | 261,597 |
| 2025-10-15 | 274,895 | -21.4% | 1.00 | 576,513 |
| 2025-09-30 | 349,546 | -3.4% | 1.00 | 1,347,286 |
import finzdata as yf
yf.Ticker("KAPA").short_interest # every report since 2017
yf.Client().short_interest(["KAPA"], start="2018-01-01")Healthcare short interest · KAPA price history · Who owns KAPA · All short interest